$227.99+0.68 (+0.30%)
Market open · 15-min delayed · as of 11:09 AM ET
Ascendis Pharma A/S · Tenets
How ASND measures up against value, income, timing, and long-hold tenets. Every criterion shows the live number and the pass rule. Always free.
The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).
1 / 17 qualify todayas of 2026-10-02 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
1
meet every gate today
BORDERLINE
1
within one input of the gate
FAILS
6
miss at least one gate
UNKNOWN
9
insufficient data to judge
passesfailsborderlineunknown
Value — six classic philosophies
Buffett Qualitydurable moat
— Insufficient inputs (2 of 5 known)Unknown — no dataROE ≥ 15%— · ≥ 15.0%
PassesGross margin ≥ 40%(fiscal 2025: files no quarterly statements)86.8% · ≥ 40.0%
FailsNet margin ≥ 15%(fiscal 2025: files no quarterly statements)−31.7% · ≥ 15.0%
Unknown — no dataDebt/equity ≤ 0.5— · ≤ 0.50
Unknown — no dataGrowing FCF (multi-yr)— · > 0
Verdict Unknown for this set.Verdict Unknown for this set. 2 of 5 checks below carry data.Buffett Quality under The screens ›
Piotroski F-Scorefinancial strength
~ 6 / 9FailsReturn on assets positive(fiscal 2025)−17.5% · > 0
PassesOperating cash flow positive(fiscal 2025)$63.3M · > 0
PassesReturn on assets improving(fiscal 2025)−32.1% → −17.5%
PassesEarnings backed by cash (CFO > net income)(fiscal 2025)$63.3M vs −$267.6M
PassesLeverage falling (long-term debt / assets)(fiscal 2025)72.6% → 66.9%
PassesCurrent ratio improving(fiscal 2025)10.50 → 10.65
FailsNo share dilution (≤ +2%)(fiscal 2025)+2.1%
FailsGross margin expanding(fiscal 2025)87.8% → 86.8%
PassesAsset turnover improving(fiscal 2025)0.31 → 0.55
Decided by the pass rule for Piotroski F-Score.The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here. These checks score 6 of 9.Piotroski F-Score under The screens ›
Munger Compoundershigh-ROIC quality
— Insufficient inputs (1 of 3 known)Unknown — no dataROIC ≥ 15%— · ≥ 15.0%
Unknown — no dataNet debt/EBITDA ≤ 3×— · ≤ 3.0×
PassesAltman Z ≥ 3 (safe zone)(fiscal 2025: files no quarterly statements)5.67 · ≥ 3.00
Verdict Unknown for this set.Verdict Unknown for this set. 1 of 3 checks below carry data.Munger Compounders under The screens ›
Magic FormulaROC + earnings yield (threshold check; full rank needs universe)
— Insufficient inputs (1 of 3 known)FailsEBIT > 0(fiscal 2025: files no quarterly statements)−$159.9M · > 0
Unknown — no dataEarnings yield EBIT/EV ≥ 6%— · ≥ 6.0%
Unknown — no dataReturn on capital ≥ 25%— · ≥ 25.0%
Verdict Unknown for this set.Verdict Unknown for this set. 1 of 3 checks below carry data. The pass rule for Magic Formula is not published separately on the methodology page.About this screen ›
Graham Defensivemargin of safety
— Insufficient inputs (3 of 7 known)PassesSize: market cap ≥ $2B$14.1B · ≥ $2.0B
PassesCurrent ratio ≥ 2(fiscal 2025: files no quarterly statements)10.65 · ≥ 2.00
FailsPositive EPS 10y0y
Unknown — no dataPays a dividend— · > 0
Unknown — no dataEPS growth ≥ 3%/yr— · ≥ 3.0%
Unknown — no dataP/E ≤ 15— · ≤ 15.00
Unknown — no dataP/E × P/B ≤ 22.5— · ≤ 22.50
Verdict Unknown for this set.Verdict Unknown for this set. 3 of 7 checks below carry data.Graham Defensive under The screens ›
Lynch GARPgrowth at reasonable price (historical-CAGR basis)
— UnknownUnknown — no dataPEG < 1 (hist. growth)— · < 1.00
Unknown — no dataEPS growth 10–30%— · 10.0%–30.0%
Verdict Unknown for this set.Verdict Unknown for this set. None of the 2 checks below carry data.Lynch GARP under The screens ›
Income — dividend safety
Income & Dividend Safetycoverage over headline yield
— UnknownUnknown — no dataPays a dividend— · > 0
Unknown — no dataYield in a healthy band (not a yield trap)— · 1.0%–8.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataEarnings payout not stretched— · ≤ 75.0%
Unknown — no dataBalance sheet can sustain the payout— · ≤ 4.0×
Verdict Unknown for this set.Verdict Unknown for this set. None of the 5 checks below carry data. The pass rule for Income & Dividend Safety is not published separately on the methodology page.
Dividend Growthraises you can count on
— UnknownUnknown — no dataPays a dividend— · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.Verdict Unknown for this set. None of the 6 checks below carry data.Dividend Growth under The screens ›
Long Hold — quality compounders
Quality Compounderhigh returns, reinvested, few new shares
✕ FailsFailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 4 on file
PassesRevenue compounding ≥ 8%/yr over 5 years150.9% per year · ≥ 8.0%
FailsNot diluting: diluted share count flat-to-down (≤ +1%/yr)4.4% · ≤ 1.0%
FailsFree cash flow margin ≥ 12%6.3% · ≥ 12.0%
Not scored: see the reason belowEarnings backed by cash (operating cash flow ≥ net income)A loss year makes cash-vs-earnings unreadable: the ratio inverts over negative net income, so it is not scored (never counted against).— · ≥ 1.00
Reading: does not hold. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check4.4%
Decided by the pass rule for Quality Compounder.The pass rule for Quality Compounder is what decides that verdict, and it is not restated here. 1 of 5 carry no data. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›
Timing — dip & swing receipts
Drawdown Contexta dip, not a collapse
— Insufficient inputs (2 of 6 known)Unknown — no dataOff its 52-week high by 8–35% (a dip, not a collapse)— · 8.0%–35.0%
FailsDip within its own normal pullback band0.19
Unknown — no dataNot past where its dips have historically recovered from1.58
Unknown — no dataA dip in an uptrend (above a rising 200-day)—
FailsHigher-low structure still intactstructure broken · higher low
Unknown — no dataClear of the earnings blackout (more than 5 days out)— · > 5.00
Verdict Unknown for this set.Verdict Unknown for this set. 2 of 6 checks below carry data. The pass rule for Drawdown Context is not published separately on the methodology page.
Reversal Evidencedaily close onlysigns the pullback is turning
✕ FailsUnknown — no dataA bullish MACD cross within 10 sessions— · ≤ 10.00
FailsReclaimed a rising 50-day EMA245.68
PassesPrinted a higher lowyes
FailsA volume thrust on the turn (≥ 1.2× normal)0.83 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)1.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
Not-a-Value-Trap Gatecheap for a good reason, not a broken one
✓ QualifiesUnknown — no dataIn the cheap half of its own 5-year valuation range—
PassesEarnings estimates not being cut0.04
PassesReturns on capital not deteriorating−0.13
Decided by the pass rule for Not-a-Value-Trap Gate.The pass rule for Not-a-Value-Trap Gate is what decides that verdict, and it is not published separately on the methodology page. 1 of 3 carry no data.
Quality Floorpasses the quality/value gate on this dip
✕ FailsFailsOperating profit is positive(fiscal 2025: files no quarterly statements)−$159.9M · > 0
FailsReturn on invested capital ≥ 10%(fiscal 2025: files no quarterly statements)−13.5% · ≥ 10.0%
Not scored: see the reason belowA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)(fiscal 2025: files no quarterly statements)Net debt / EBITDA cannot be read over non-positive EBITDA: the ratio flips sign, so a net-cash company prints a healthy-looking positive. Only the Altman Z half, shown beside this line, is measurable, so the test is left unscored rather than counted either way.5.7×
PassesQuality score ≥ 5053.70 · ≥ 50.00
PassesRevenue growing over 5 years(fiscal 2020 to 2025)150.9% per year · > 0
Decided by the pass rule for Quality Floor.The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
Qualified Dipa pullback with receipts, not a falling knife
— Insufficient inputs (3 of 4 known)A research signal from published criteria, not a recommendation.
Unknown — no dataDrawdown context0 of 6 held · 4 no data
FailsReversal evidence1 of 4 signals fired
PassesTrap gate2 of 3 held · 1 no data
FailsQuality floor2 of 5 held · 1 no data
Invalidation level (structure break): below this the dip's structure has broken$243.45
Verdict Unknown for this set.Verdict Unknown for this set. No price factors yet: the timing receipts populate after the nightly engine runs.Qualified Dip under The screens ›
Trend Alignmentprice in a confirmed uptrend
✕ FailsFailsTrading above its 50-day average249.19
Unknown — no dataTrading above its 200-day average—
Unknown — no data50-day average above the 200-day (uptrend stack)249.19
Fails50-day average sloping up−0.03 · > 0
Decided by the pass rule for Trend Alignment.The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page. 2 of 4 carry no data.
Relative Strengthoutperforming, ranked vs the universe
✕ FailsFails3-month return in the top half of the universe0.24 · ≥ 0.50
Unknown — no data12-minus-1 momentum in the top half of the universe— · ≥ 0.50
FailsRelative strength vs the S&P 500 improving−0.00 · > 0
PassesEarnings estimates being revised up0.04
Decided by the pass rule for Relative Strength.The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Momentum Triggera trigger you can see
✕ FailsFailsMACD above its signal line−7.76
Not scored: see the reason belowBack above the 50-day on a fresh cross (≤10 sessions)This is a two-part reading (price back above the 50-day, and a bullish momentum cross inside 10 sessions) and a dated momentum cross is not on record for this name yet, so it is left unscored rather than counted either way.—
FailsHigher high and higher low (stair-stepping up)no higher high · higher low
FailsA volume thrust on the move (≥ 1.2× normal)0.83 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Volatility Regimecontext, not a signal
Context, not scoredAverage daily swing: elevated0.04
Volatility band width: expanded (wide range)0.87
Distance from its 52-week high—
✓
Every verdict is auditableEach criterion shows the live number and the pass rule side by side — a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
!
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.
Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.